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The spread of antimicrobials resistant microorganisms has triggered the search for new ways to 
treat infections. One of these ways is the creation of antimicrobial devices and surfaces that kill 
or prevent the spread of microorganisms. In the present work we explored the properties of 
different antimicrobial peptides (AMPs) for the creation of biopolymers with broad antimicrobial 
activity. Antimicrobial recombinant protein-based polymers (rPBPs) were designed by cloning 
the DNA sequence coding for the different AMPs in frame with the N-terminus of the elastin-like 
recombinamer consisting of 200 repetitions of the pentamer VPAVG, here named A200. The new 
rPBPs, CM4-A200, BMAP-18A200 and Hep-A200, were purified via a simplified 
nonchromatographic method, making use of the thermoresponsive behavior of the A200 polymer. 
While the Hep-A200 polymer displayed antibacterial activity in the soluble state, CM4-A200 and 
BMAP-18A200 were poorly effective in solution. However, when CM4-A200 and BMAP-
18A200 were processed into free-standing films high antimicrobial activity against Gram-positive 
and Gram-negative bacteria, yeasts and filamentous fungi was observed. The antimicrobial 
activity of these films was dependent on the physical contact of cells with the film surface. 
Furthermore, the antimicrobial films did not reveal a cytotoxic effect against both normal human 
skin fibroblasts and human keratinocytes. Finally, we have developed an optimized ex vivo assay 
with pig skin demonstrating the antimicrobial properties of the CM4-A200 cast films for skin 
applications. 
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